Skip to main content

Our roundup of Canadian small-caps of between $100-million and $2.5-billion in market capitalization making news and on the move today.

Well Health Technologies Corp. (WELL-T) announced it's buying Mississauga, Ont.-based Oscarservice Inc., doing business as Trinity Healthcare Technologies, for about $7.2-million in cash and shares.

"As Canada's second-largest OSCAR service provider, THT will be a key asset in our consolidation of the OSCAR EMR marketplace and substantially increases our footprint in Ontario with over 500 clinics in its service portfolio," said Hamed Shahbazi, Well's chairman and CEO.

Story continues below advertisement

**

Knight Therapeutics Inc. (GUD-T) announced that it and Israel-based Medison Biotech (1995) Ltd. have agreed to separate their businesses "and allow each of the companies to focus on growing their respective businesses independently."

Knight said it will sell its 28.3-per-cent stake in Medison to the company for $77-million in cash. "In addition, the parties agreed to release each other from all claims and withdraw all legal proceedings initiated by both parties," Knight stated.

Medison, which together with its affiliates own approximately 10.4 million shares or 7.5 per cent of Knight, also agreed to a four-year standstill commitment and will divest its position in Knight during this period, the company said.

**

Equinox Gold Corp. (EQX-X) announced it has received approval to graduate from the TSX Venture Exchange to the Toronto Stock Exchange on Nov. 25.

"Graduating to the Toronto Stock Exchange is another important milestone for Equinox Gold, reflecting the company's growth over the last two years from a single-asset developer to a multi-mine producer," stated CEO Christian Milau. "Completing both TSX and NYSE American stock exchange listings achieves the company's objective of increasing market visibility and enhancing trading flexibility for investors."

Story continues below advertisement

**

Auxly Cannabis Group Inc. (XLY-X) reported third-quarter revenue of $1.6-million up from $818,000 a year ago. The expectation was for revenue to come in at $1.7-million. The company reported a net loss was $17.3-million or 3 cents per share compared with a loss of $9.6-million or 2 cents a year earlier.

Report an error Editorial code of conduct
Tickers mentioned in this story
Unchecking box will stop auto data updates
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies